Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

Study Finds Insurance Status Affects Survival in Glioblastoma

August 24th 2016, 11:23pm

Article

Being insured by Medicaid may affect the prognosis of a patient with GBM, according to a recent study.

Proactive or Reactive Cancer Treatment (Part 2)

August 24th 2016, 10:18am

Article

Greg continues his treatment journey for GBM.

End Brain Cancer: Making Life-Saving Connections

August 17th 2016, 7:26pm

Article

By funding research and connecting patients with researchers, doctors and clinical trials, End Brain Cancer is hoping that more people will survive the disease.

NCCN Strengthens Recommendation for Optune in Glioblastoma Multiforme

July 29th 2016, 12:29am

Article

The NCCN recently designated Optune, which has been shown to slow and reverse tumor growth, a category 2A recommendation for some patients with GBM.

Improved Optune System Approved for Glioblastoma Multiforme

July 14th 2016, 2:54am

Article

The FDA has approved a lighter and more convenient version of the tumor-treating field device Optune for patients with glioblastoma multiforme.

BTSM Provides a Sense of Community for Patients With Brain Tumors

July 13th 2016, 6:08pm

Article

CURE spoke with Liz Salmi on connecting people with brain tumors via social media.

Greg Cantwell on the Importance of Hope When Facing a GBM Diagnosis

June 23rd 2016, 9:57pm

Video

Greg Cantwell, founder of Greg’s Mission, discusses the importance of having hope after getting a glioblastoma multiforme (GBM) diagnosis.

Phase 3 Study of Temozolomide Could Change Standard Care for Anaplastic Glioma

June 14th 2016, 8:35pm

Article

Temozolomide may have survival benefits for certain patients with brain cancer, according to a recent study.

Antiangiogenic Gene Therapy, Added to Standard Treatment, Boosts Survival in Recurrent Glioblastoma

June 10th 2016, 1:30am

Article

Avastin plus a novel antiangiogenic gene therapy resulted in significantly better overall survival for patients with recurrent glioblastoma multiforme.

Opdivo Safe, Effective in Early Stage Glioblastoma

June 9th 2016, 11:47pm

Article

Opdivo showed a higher-than-average OS rate and presented no grade 3/4 adverse events in patients with recurrent glioblastoma multiforme, according to a recent study.